Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia

Psychiatry Research - Neuroimaging

Volumn 154, Issue 1, 2007, Pages 49-58

  Fujimoto, Toshiro ^a   Takeuch, Kouzou ^b   Matsumoto, Tetsuro ^b   Kamimura, Kiyohisa ^b   Hamada, Ryuichiro ^b   Nakamura, Katsumi ^b   Kato, Nobumasa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Yokakai Foundation   (Japan)

Author keywords

Anterior cingulate cortex; FDG PET; Gender difference; Glucose metabolism; Prefrontal cortex; Schizophrenia

Indexed keywords

BROMPERIDOL; CARBAMAZEPINE; CHLORPROMAZINE; FLUORODEOXYGLUCOSE F 18; HALOPERIDOL; LEVOMEPROMAZINE; MOSPARAMINE; NEUROLEPTIC AGENT; OLANZAPINE; PERICIAZINE; PEROSPIRONE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SULTOPRIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN DYSFUNCTION; BRAIN MAPPING; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DATA ANALYSIS; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; FRONTAL CORTEX; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; LEFT HEMISPHERE; MALE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RIGHT HEMISPHERE; SCHIZOPHRENIA; SENSORY SYSTEM; SEX DIFFERENCE; TEMPORAL LOBE; THALAMUS; THREE DIMENSIONAL IMAGING;

ADULT; BASAL GANGLIA; BLOOD GLUCOSE; BRAIN MAPPING; DOMINANCE, CEREBRAL; FEMALE; FLUORODEOXYGLUCOSE F18; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; NERVE NET; PARIETAL LOBE; POSITRON-EMISSION TOMOGRAPHY; SCHIZOPHRENIA, DISORGANIZED; SCHIZOPHRENIA, PARANOID; SEX FACTORS; TEMPORAL LOBE; THALAMUS;

EID: 33846080910     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2006.04.002     Document Type: Article

References (42)

1. Bartlett E.J., Brodie J.D., Simkowitz P., Dewey S.L., Rusinek H., Wolf A.P., Fowler J.S., Volkow N.D., Smith G., Wolkin A., and Cancro R. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. American Journal of Psychiatry 151 (1994) 681-686
2. Bartley A.J., Jones D.W., and Weinberger D.R. Genetic variability of human brain size and cortical gyral patterns. Brain 120 (1997) 257-269
3. Benes F.M. Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain. Schizophrenia Bulletin 24 (1998) 219-230
4. Benes F.M., Davidson J., and Bird E.D. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Archives of General Psychiatry 43 (1986) 31-35
5. Benes F.M., Vincent S.L., Alsterberg G., Bird E.D., and SanGiovanni J.P. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. Journal of Neuroscience 12 (1992) 924-929
6. Buchsbaum M.S., and Hazlett E.A. Functional brain imaging and aging in schizophrenia. Schizophrenia Research 27 (1997) 129-141
7. Buchsbaum M.S., and Hazlett E.A. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophrenia Bulletin 24 (1998) 343-364
8. Buchsbaum M.S., Ingvar D.H., Kessler R., Waters R.N., Cappelletti J., van Kammen D.P., King A.C., Johnson J.L., Manning R.G., Flynn R.W., Mann L.S., Bunney Jr. W.E., and Sokoloff L. Cerebral glucography with positron tomography: use in normal subjects and in patients with schizophrenia. Archives of General Psychiatry 39 (1982) 251-259
9. Buchsbaum M.S., DeLisi L.E., Holcomb H.H., Cappelletti J., King A.C., Johnson J., Hazlett E., Dowling-Zimmerman S., Post R.M., Morihisa J., Carpenter W., Cohen R., Pickar D., Weinberger D.R., Margolin R., and Kessler R.M. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Archives of General Psychiatry 41 (1984) 1159-1166
10. Buchsbaum M.S., Wu J.C., DeLisi L.E., Holcomb H.H., Hazlett E., Cooper-Langston K., and Kessler R. Positron emission tomography study of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biological Psychiatry 22 (1987) 479-494
11. Buchsbaum M.S., Haier R.J., Potkin S.G., Nuechterlein K., Bracha H.S., Katz M., Lohr J., Wu J., Lottenberg S., Jerabek P.A., Trenary M., Tafalla R., Reynolds C., and Bunney Jr. W.E. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Archives of General Psychiatry 49 (1992) 935-942
12. Buchsbaum M.S., Potkin S.G., Siegel Jr. B.V., Lohr J., Katz M., Gottschalk L.A., Gulasekaram B., Marshall J.F., Lottenberg S., Teng C.Y., Abel L., Plon L., and Bunney Jr. W.E. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Archives of General Psychiatry 49 (1992) 966-974
13. Burdette J.H., Minoshima S., Borght T.V., Tran D.D., and Kuhl D.E. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 198 (1996) 837-843
14. Bush G., Luu P., and Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends in Cognitive Sciences 4 (2000) 215-222
15. Bush G., Shin L.M., Holmes J., Rosen B.R., and Vogt B.A. The multi-source interference task: validation study with fMRI in individual subjects. Molecular Psychiatry 8 (2003) 60-70
16. DeLisi L.E., Holcomb H.H., Cohen R.M., Pickar D., Carpenter W., Morihisa J.M., King A.C., Kessler R., and Buchsbaum M.S. Positron emission tomography in schizophrenic patients with and without neuroleptic medication. Journal of Cerebral Blood Flow and Metabolism 5 (1985) 201-206
17. Dolan R.J., Fletcher P., Frith C.D., Friston K.J., Frackowiak R.S.J., and Grasby P.M. Dopaminergic modulation of impaired cognitive activation in the anoterior cingulate cortex in schizophrenia. Nature 378 (1995) 180-182
18. Farkas T., Wolf A.P., Jaeger J., Brodie J.D., Christman D.R., and Fowler J.S. Regional brain glucose metabolism in chronic schizophrenia. Archives of General Psychiatry 41 (1984) 293-300
19. Fletcher P., McKenna P.J., Friston K.J., Frith C.D., and Dolan R.J. Abnormal cingulate modulation of fronto-temporal connectivity in schizophrenia. Neuroimage 9 (1999) 337-342
20. Flor-Henry P. Cerebral Basis of Psychopathology (1983), John Wright-PSG Inc., USA
21. Geschwind N., and Galaburda A.M. Cerebral lateralization: biological mechanisms, associations, and pathology: II. A hypothesis and a program for research. Archives of Neurology 42 (1985) 521-552
22. Goldstein J.M., Goodman J.M., Seidman L.J., Kennedy D.N., Makris N., Lee H., Tourville J., Caviness Jr. V.S., Faraone S.V., and Tsuang M.T. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Archives of General Psychiatry 56 (1999) 537-547
23. Goldstein J.M., Seidman L.J., O'Brien L.M., Horton N.J., Kennedy D.N., Makris N., Caviness Jr. V.S., Faraone S.V., and Tsuang M.T. Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Archives of General Psychiatry 59 (2002) 154-164
24. Holcomb H.H., Cascella N.G., Thaker G.K., Medoff D.R., Dannals R.F., and Tamminga C.A. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. American Journal of Psychiatry 153 (1996) 41-49
25. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology 28 (2003) 17-54
26. Katz M., Buchsbaum M.S., Siegel Jr. B.V., Wu J., Haier R.J., and Bunney Jr. W.E. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology 33 (1996) 1-11
27. Kling A.S., Metter E.J., Riege W.H., and Kuhl D.E. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. American Journal of Psychiatry 143 (1986) 175-180
28. Lahti A.C., and Holcomb H.H. Schizophrenia, VIII. American Journal of Psychiatry 160 (2003) 2091
29. Liddle P.F., Friston K.J., Frith C.D., Hirsch S.R., Jones T., and Frackowiak R.S.J. Patterns of cerebral blood flow in schizophrenia. British Journal of Psychiatry 160 (1992) 179-186
30. Minoshima S. Imaging Alzheimer's disease: clinical applications. Neuroimaging Clinics of North America 13 (2003) 769-780
31. Minoshima S., Frey K.A., Koeppe R.A., Foster N.L., and Kuhl D.E. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. Journal of Nuclear Medicine 36 (1995) 1238-1248
32. Minoshima S., Ficaro E.P., Frey K.A., Koeppe R.A., and Kuhl D.E. Data extraction from brain PET images using three-dimensional stereotactic surface projections. In: Myers R., Cunningham V., Bailey D., and Jones T. (Eds). Quantification of Brain Function Using PET (1998), Academic Press, San Diego 133-137
33. Molina V., Sanz J., Sarramea F., Luque R., Benito C., and Palomo T. Dorsolateral prefrontal and superior temporal volume deficits in first-episode psychoses that evolve into schizophrenia. European Archives of Psychiatry and Clinical Neuroscience 256 (2006) 106-111
34. Ngan E.T.C., Lane C.J., Ruth T.J., and Liddle P.F. Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change. Journal of Neurology, Neurosurgery and Psychiatry 72 (2002) 106-110
35. Seeman M.V., and Lang M. The role of estrogens in schizophrenia gender differences. Schizophrenia Bulletin 16 (1990) 185-194
36. Soyka M., Koch W., Möller H.J., Rüther T., and Tatsch K. Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients: results from a FDG-PET study. European Archives of Psychiatry and Clinical Neuroscience 255 (2005) 308-312
37. Szechtman H., Nahmias C., Garnett E.S., Firnau G., Brown G.M., Kaplan R.D., and Cleghorn J.M. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Archives of General Psychiatry 45 (1988) 523-532
38. Talairach J., and Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain (1988), Thieme Medical Publishers Inc., New York
39. Vogt B.A., Nimchinsky E.A., Vogt L.J., and Hof P.R. Human cingulate cortex: surface features, flat maps, and cytoarchitecture. Journal of Comparative Neurology 359 (1995) 490-506
40. 18F]fluorodeoxyglucose (FDG). European Neuropsychopharmacology 7 (1997) 9-24
41. Wolkin A., Jaeger J., Brodie J.D., Wolf A.P., Fowler J., Rotrosen J., Gomez-Mont F., and Cancro R. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. American Journal of Psychiatry 142 (1985) 564-571
42. Yücel M., Stuart G.W., Maruff P., Wood S.J., Savage G.R., Smith D.J., Crowe S.F., Copolov D.L., Velakoulis D., and Pantelis C. Paracingulate morphologic differences in males with established schizophrenia: a magnetic resonance imaging morphometric study. Biological Psychiatry 52 (2002) 15-23